Search

everythinglearnresearchcommunity

for

Search:↓

Pattern baldness is likely caused by a dominant gene influenced by testosterone levels, making it more common in men.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

DHT, a testosterone byproduct, causes male pattern baldness.

These drugs cause hair growth without affecting testosterone or adrenal hormones.

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

Testosterone is crucial for development, growth, and various body functions in mammals.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Postmenopausal hyperandrogenism, a condition with symptoms like increased hair growth and acne, is usually caused by PCOS but can also be due to other factors. It's diagnosed by checking testosterone levels and treated either by removing the adrenal tumor or through antiandrogen therapy.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Managing oxidative stress might help treat low testosterone and related chronic diseases in aging men.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

The document concludes that accurate diagnosis and management of PCOS are crucial due to its associated health risks.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Overweight women with PCOS are more likely to have excess male hormones.

Girls with PCOS have higher levels of certain androgens, which are linked to excess hair growth, but these androgens don't help diagnose PCOS.

Suppressing certain hormones might help prevent prostate cancer.

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

Hormonal treatments, including birth control and antiandrogens, can effectively treat acne in women.

The document concludes that treating PCOS requires a combination of drugs to manage reproductive and metabolic symptoms, with more research needed on combination therapies.

Birth control pills and cyproterone acetate can help treat acne in women, especially when linked to hormonal issues.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Hirsutism causes significant psychological distress in women.

Finasteride gel effectively and safely reduces hair thickness in women with excessive hair growth.

Manage PCOS in primary care with weight loss, psychological support, medication, and monitoring for health risks.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.